{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:12:10Z","timestamp":1785726730588,"version":"3.56.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-03944-2","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T11:26:50Z","timestamp":1739532410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of clinical efficacy in melasma treatment with picosecond laser combined with Shumin Star"],"prefix":"10.1007","volume":"317","author":[{"given":"Xuejiao","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"3944_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.15562\/bmj.v11i1.3182","volume":"11","author":"AK Devi","year":"2022","unstructured":"Devi AK et al (2022) Profile of melasma patients in dermatology and venerology outpatient clinic Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. Bali Med J 11:166\u2013173","journal-title":"Bali Med J"},{"key":"3944_CR2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jaad.2011.06.001","volume":"65","author":"VM Sheth","year":"2011","unstructured":"Sheth VM, Pandya AG (2011) Melasma: a comprehensive update: part II. J Am Acad Dermatol 65:699\u2013714","journal-title":"J Am Acad Dermatol"},{"key":"3944_CR3","doi-asserted-by":"crossref","unstructured":"McKesey J, Tovar-Garza A, Pandya AG (2020) Melasma treatment: an evidence-based review. Am J Clin Dermatol 21:173\u2013225","DOI":"10.1007\/s40257-019-00488-w"},{"key":"3944_CR4","first-page":"62","volume":"7","author":"JK Alhasan","year":"2022","unstructured":"Alhasan JK, Jaf MYS (2022) Characteristic dermoscopic signs of Melasma among patients attending dermatology-teaching centre in Sulaymaniyah city. AMJ (Advanced Med J) 7:62\u201369","journal-title":"AMJ (Advanced Med J"},{"key":"3944_CR5","unstructured":"Sarkar R, Ailawadi P, Garg S et al (2018) Melasma in men: A review of clinictiological, and management issues. J Clin Aesthet Dermatol 11:53"},{"key":"3944_CR6","doi-asserted-by":"crossref","unstructured":"Abdalla MA (2021) Melasma Clinical features, diagnosis, epidemiology and etiology: an Update Review. Siriraj Med J 73","DOI":"10.33192\/Smj.2021.109"},{"key":"3944_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/der2.178","volume":"4","author":"R Khanna","year":"2023","unstructured":"Khanna R, Nowah A, Morris D, Desai SR (2023) Pathogenesis of melasma. Dermatological Reviews 4:12\u201316","journal-title":"Dermatological Reviews"},{"key":"3944_CR8","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s13555-022-00779-x","volume":"12","author":"ACC Esp\u00f3sito","year":"2022","unstructured":"Esp\u00f3sito ACC et al (2022) Update on Melasma\u2014Part I: Pathogenesis. Dermatology Therapy 12:1967\u20131988","journal-title":"Dermatology Therapy"},{"key":"3944_CR9","doi-asserted-by":"crossref","unstructured":"Liu W, Chen Q, Xia Y (2023) New mechanistic insights of melasma. Clin Cosmet Invest Dermatol:429\u2013442","DOI":"10.2147\/CCID.S396272"},{"key":"3944_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/exd.14752","volume":"32","author":"MG Alfredo","year":"2023","unstructured":"Alfredo MG et al (2023) Depigmenting topical therapy based on a synergistic combination of compounds targeting the key pathways involved in melasma pathophysiology. Exp Dermatol 32:611\u2013619","journal-title":"Exp Dermatol"},{"key":"3944_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/jocd.15924","volume":"23","author":"H Rahimi","year":"2024","unstructured":"Rahimi H, Mirnezami M, Yazdabadi A, Hajihashemi A (2024) Evaluation of systemic oxidative stress in patients with melasma. J Cosmet Dermatol 23:284\u2013288","journal-title":"J Cosmet Dermatol"},{"key":"3944_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/DAD.0000000000002418","volume":"45","author":"JP Castanedo-C\u00e1zares","year":"2023","unstructured":"Castanedo-C\u00e1zares JP, Cort\u00e9s-Garc\u00eda JD, P\u00e9rez-Coronado G, Hern\u00e1ndez-Blanco D, Torres-Alvarez B (2023) Skin barrier function and its relationship with IL-17, IL-33, and Filaggrin in Malar Melasma. Am J Dermatopathol 45:300\u2013305","journal-title":"Am J Dermatopathol"},{"key":"3944_CR13","doi-asserted-by":"crossref","unstructured":"Goel A, Trivedi N (2023) Current updates on melasma treatments. Cosmoderma. 3","DOI":"10.25259\/CSDM_84_2023"},{"key":"3944_CR14","doi-asserted-by":"crossref","unstructured":"Mpofana N et al (2023) Treatment of melasma on darker skin types: a scoping review. Cosmetics. 10:25","DOI":"10.3390\/cosmetics10010025"},{"key":"3944_CR15","doi-asserted-by":"crossref","unstructured":"Rendon M, Berneburg M, Arellano I, Picardo M (2006) Treatment of melasma. J Am Acad Dermatol 54:S272-S281","DOI":"10.1016\/j.jaad.2005.12.039"},{"key":"3944_CR16","doi-asserted-by":"crossref","unstructured":"Mahajan VK et al (2022) Medical therapies for melasma. J Cosmet Dermatol 21:3707\u20133728","DOI":"10.1111\/jocd.15242"},{"key":"3944_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13555-014-0064-z","volume":"4","author":"K Shankar","year":"2014","unstructured":"Shankar K et al (2014) Evidence-based treatment for melasma: expert opinion and a review. Dermatology Therapy 4:165\u2013186","journal-title":"Dermatology Therapy"},{"key":"3944_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0019-5154.57602","volume":"54","author":"D Bandyopadhyay","year":"2009","unstructured":"Bandyopadhyay D (2009) Topical treatment of melasma. Indian J Dermatology 54:303\u2013309","journal-title":"Indian J Dermatology"},{"key":"3944_CR19","doi-asserted-by":"crossref","unstructured":"Lee SY et al (2023) The Efficacy and Safety of a Low-Fluence 1064 nm Picosecond ND-YAG Laser Compared with Those of a Low-Fluence Photoacoustic Therapy Pulsed (PTP) Mode 1064 nm Q-Switched ND-YAG Laser for Treatment of Melasma: A Prospective Split-Face Study. Dermatol Ther 2023","DOI":"10.1155\/2023\/5961152"},{"key":"3944_CR20","doi-asserted-by":"crossref","unstructured":"Ren R, Bao S, Qian W, Zhao H (2023) Efficacy and Safety of Picosecond Laser in the Treatment of Melasma: A Network Meta-analysis. Dermatol Surg 49:S49-S55","DOI":"10.1097\/DSS.0000000000003775"},{"key":"3944_CR21","doi-asserted-by":"crossref","unstructured":"Liang S et al (2023) Comparison of the efficacy and safety of picosecond Nd: YAG laser (1,064 nm), picosecond alexandrite laser (755 nm) and 2% hydroquinone cream in the treatment of melasma: A randomized, controlled, assessor-blinded trial. Front Med 10:1132823","DOI":"10.3389\/fmed.2023.1132823"},{"key":"3944_CR22","doi-asserted-by":"crossref","unstructured":"Pigmentary Disorder Group, C. o. T. et al (2021) Consensus on the diagnosis and treatment of melasma in China (2021 version)#. Int J Dermatol Venereol 4:133\u2013139","DOI":"10.1097\/JD9.0000000000000164"},{"key":"3944_CR23","doi-asserted-by":"publisher","unstructured":"Thapa RJ, Karki BC, Yadav SC (2022) Management of Melasma: Emerging Facts. J Tumor Sci Res. SRC\/JTSR-118 107(1):2\u20136. https:\/\/doi.org\/10.47363\/JTSR\/2022","DOI":"10.47363\/JTSR\/2022"},{"key":"3944_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/DSS.0000000000001697","volume":"45","author":"RL Torbeck","year":"2019","unstructured":"Torbeck RL et al (2019) Evolution of the picosecond laser: a review of literature. Dermatol Surg 45:183\u2013194","journal-title":"Dermatol Surg"},{"key":"3944_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1089\/photob.2023.0096","volume":"Surgery41","author":"B Pimentel","year":"2023","unstructured":"Pimentel B et al (2023) Use of Picosecond Laser for Melasma Treatment: a narrative review. Photobiomodulation Photomed Laser Surgery41:674\u2013682","journal-title":"Photobiomodulation Photomed Laser"},{"key":"3944_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10103-023-03744-y","volume":"38","author":"J Feng","year":"2023","unstructured":"Feng J, Shen S, Song X, Xiang W (2023) Efficacy and safety of picosecond laser for the treatment of melasma: a systematic review and meta-analysis. Lasers Med Sci 38:84","journal-title":"Lasers Med Sci"},{"key":"3944_CR27","unstructured":"Dai L (2022) & HONG. The efficacy and safety of Q-tuned ruby fractional laser combined with the Shu Min Star in the treatment of zygomatic nevus of brownish blue color. Chin J Aesthetic Plast Surg 33"},{"key":"3944_CR28","first-page":"1563","volume":"136","author":"J Wan","year":"2023","unstructured":"Wan J, Liao Z, Dong B, Jiang S, Lei T (2023) Targeting senescent dermal fibroblasts responsible for hyperactive melanocytes in melasma. Chin Med J 136:1563\u20131565","journal-title":"Chin Med J"},{"key":"3944_CR29","doi-asserted-by":"crossref","unstructured":"Pulumati A, Jaalouk D, Algarin YA, Nouri K (2023) The role of 755-nm alexandrite picosecond laser in melasma management. Arch Dermatol Res 316:60","DOI":"10.1007\/s00403-023-02794-0"},{"key":"3944_CR30","doi-asserted-by":"crossref","unstructured":"Harnchoowong S, Vachiramon V, Jurairattanaporn N (2024) Cosmetic considerations in Dark-Skinned patients. Clin Cosmet Invest Dermatol 259\u2013277","DOI":"10.2147\/CCID.S450081"},{"key":"3944_CR31","first-page":"440","volume":"74","author":"L Nguyen","year":"2023","unstructured":"Nguyen L, Schneider SW, Herberger K (2023) Picosecond lasers in dermatology. Dermatologie (Heidelberg, Germany) 74:440\u2013447","journal-title":"Dermatologie (Heidelberg Ger"},{"key":"3944_CR32","unstructured":"Wardhani PH, Prakoeswa CRS, Listiawan MY. Proceedings of the 6th International Conference on Medical and Health Informatics. 229\u2013233"},{"key":"3944_CR33","doi-asserted-by":"crossref","unstructured":"Choi YJ et al (2017) Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: a prospective, randomized, multicenter, split-face, 2% hydroquinone cream\u2010controlled clinical trial. Lasers Surg Med 49:899\u2013907","DOI":"10.1002\/lsm.22735"},{"key":"3944_CR34","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1111\/j.1468-3083.2011.04337.x","volume":"26","author":"D Lee","year":"2012","unstructured":"Lee D et al (2012) Defective barrier function in melasma skin. J Eur Acad Dermatol Venereol 26:1533\u20131537","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03944-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-03944-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03944-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T22:54:13Z","timestamp":1739573653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-03944-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3944"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-03944-2","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was conducted in accordance with the Helsinki Declaration of the World Medical Association and approved by the Ethics Committee of Affiliated Hospital of Army Military Medical University Officer School. Informed consent was obtained from all the study subjects before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"406"}}